Skip to content

Clinical trials

Phase 2 Mucocutaneous Lymph Node Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucocutaneous Lymph Node Syndrome Phase: Phase 2 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20131
20162
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
Hawaii Pacific Health1
Michael Portman1
National Heart, Lung, and Blood Institute (NHLBI)1
National Taiwan University Hospital1
New York Medical College1
Novartis Pharmaceuticals1
Pontificia Universidad Catolica de Chile1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucocutaneous Lymph Node Syndrome8
Coronary Aneurysm5
Cardiovascular Diseases1
Heart Diseases1

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.